Search Results - "Banerjee, Sangeeta R"

Refine Results
  1. 1

    A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile by Boinapally, Srikanth, Ahn, Hye-Hyun, Cheng, Bei, Brummet, Mary, Nam, Hwanhee, Gabrielson, Kathleen L., Banerjee, Sangeeta R., Minn, Il, Pomper, Martin G.

    Published in Scientific reports (29-03-2021)
    “…Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of advanced prostate cancer (PC) and various solid tumors. Although…”
    Get full text
    Journal Article
  2. 2

    PSMA-Targeted Theranostic Nanoplex for Prostate Cancer Therapy by Chen, Zhihang, Penet, Marie-France, Nimmagadda, Sridhar, Li, Cong, Banerjee, Sangeeta R, Winnard, Paul T, Artemov, Dmitri, Glunde, Kristine, Pomper, Martin G, Bhujwalla, Zaver M

    Published in ACS nano (25-09-2012)
    “…Theranostic imaging, where diagnosis is combined with therapy, is particularly suitable for a disease that is as complex as cancer, especially now that genomic…”
    Get full text
    Journal Article
  3. 3

    Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen by Chen, Ying, Pullambhatla, Mrudula, Banerjee, Sangeeta R, Byun, Youngjoo, Stathis, Marigo, Rojas, Camilo, Slusher, Barbara S, Mease, Ronnie C, Pomper, Martin G

    Published in Bioconjugate chemistry (19-12-2012)
    “…Targeted near-infrared (NIR) optical imaging can be used in vivo to detect specific tissues, including malignant cells. A series of NIR fluorescent ligands…”
    Get full text
    Journal Article
  4. 4

    Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA) by Banerjee, Sangeeta R, Foss, Catherine A, Castanares, Mark, Mease, Ronnie C, Byun, Youngjoo, Fox, James J, Hilton, John, Lupold, Shawn E, Kozikowski, Alan P, Pomper, Martin G

    Published in Journal of medicinal chemistry (14-08-2008)
    “…The prostate-specific membrane antigen (PSMA) is increasingly recognized as a viable target for imaging and therapy of cancer. We prepared seven…”
    Get full text
    Journal Article
  5. 5

    Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA) by Chandran, Sachin S., R. Banerjee, Sangeeta, C. Mease, Ron, Pomper, Martin G., R. Denmeade, Samuel

    Published in Cancer biology & therapy (01-06-2008)
    “…Polymeric nanoparticles represent a form of targeted therapy due to their ability to passively accumulate within the tumor interstitium via the enhanced…”
    Get full text
    Journal Article
  6. 6

    111 In- and IRDye800CW-Labeled PLA-PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues by Banerjee, Sangeeta R, Foss, Catherine A, Horhota, Allen, Pullambhatla, Mrudula, McDonnell, Kevin, Zale, Stephen, Pomper, Martin G

    Published in Biomacromolecules (09-01-2017)
    “…Targeted delivery of drug-encapsulated nanoparticles is a promising new approach to safe and effective therapeutics for cancer. Here we investigate the…”
    Get full text
    Journal Article
  7. 7

    PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer by Chen, Zhihang, Penet, Marie-France, Krishnamachary, Balaji, Banerjee, Sangeeta R, Pomper, Martin G, Bhujwalla, Zaver M

    Published in Biomaterials (01-02-2016)
    “…Abstract Metastatic prostate cancer causes significant morbidity and mortality and there is a critical unmet need for effective treatments. We have developed a…”
    Get full text
    Journal Article
  8. 8

    Heterobivalent Agents Targeting PSMA and Integrin‑αvβ3 by Shallal, Hassan M, Minn, Il, Banerjee, Sangeeta R, Lisok, Ala, Mease, Ronnie C, Pomper, Martin G

    Published in Bioconjugate chemistry (19-02-2014)
    “…Differential expression of surface proteins on normal vs malignant cells provides the rationale for the development of receptor-, antigen-, and…”
    Get full text
    Journal Article
  9. 9

    MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided Therapy by Ngen, Ethel J, Benham Azad, Babak, Boinapally, Srikanth, Lisok, Ala, Brummet, Mary, Jacob, Desmond, Pomper, Martin G, Banerjee, Sangeeta R

    Published in Molecular pharmaceutics (06-05-2019)
    “…Magnetic nanoparticle (MNP)-induced hyperthermia is currently being evaluated for localized prostate cancer. We evaluated the feasibility of tumor-selective…”
    Get full text
    Journal Article
  10. 10

    Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer by Shen, Colette J, Minn, Il, Hobbs, Robert F, Chen, Ying, Josefsson, Anders, Brummet, Mary, Banerjee, Sangeeta R, Brayton, Cory F, Mease, Ronnie C, Pomper, Martin G, Kiess, Ana P

    Published in Theranostics (01-01-2020)
    “…Auger radiopharmaceutical therapy is a promising strategy for micrometastatic disease given high linear energy transfer and short range in tissues, potentially…”
    Get full text
    Journal Article
  11. 11

    Evaluation of a PSMA-targeted BNF nanoparticle construct by Behnam Azad, Babak, Banerjee, Sangeeta R, Pullambhatla, Mrudula, Lacerda, Silvia, Foss, Catherine A, Wang, Yuchuan, Ivkov, Robert, Pomper, Martin G

    Published in Nanoscale (14-03-2015)
    “…Early detection enables improved prognosis for prostate cancer (PCa). A promising target for imaging and therapy of PCa is the prostate-specific membrane…”
    Get more information
    Journal Article
  12. 12

    Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization by Barinka, Cyril, Byun, Youngjoo, Dusich, Crystal L, Banerjee, Sangeeta R, Chen, Ying, Castanares, Mark, Kozikowski, Alan P, Mease, Ronnie C, Pomper, Martin G, Lubkowski, Jacek

    Published in Journal of medicinal chemistry (25-12-2008)
    “…Urea-based, low molecular weight ligands of glutamate carboxypeptidase II (GCPII) have demonstrated efficacy in various models of neurological disorders and…”
    Get full text
    Journal Article
  13. 13

    111In- and IRDye800CW-Labeled PLA–PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues by Banerjee, Sangeeta R, Foss, Catherine A, Horhota, Allen, Pullambhatla, Mrudula, McDonnell, Kevin, Zale, Stephen, Pomper, Martin G

    Published in Biomacromolecules (09-01-2017)
    “…Targeted delivery of drug-encapsulated nanoparticles is a promising new approach to safe and effective therapeutics for cancer. Here we investigate the…”
    Get full text
    Journal Article
  14. 14

    Probing In Vivo Trafficking of Polymer/DNA Micellar Nanoparticles Using SPECT/CT Imaging by Patil, Rajesh R, Yu, Jianhua, Banerjee, Sangeeta R, Ren, Yong, Leong, Derek, Jiang, Xuan, Pomper, Martin, Tsui, Benjamin, Kraitchman, Dara L, Mao, Hai-Quan

    Published in Molecular therapy (01-09-2011)
    “…Successful translation of nonviral gene delivery to therapeutic applications requires detailed understanding of in vivo trafficking of the vehicles. This…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer by LeBeau, Aaron M., Banerjee, Sangeeta R., Pomper, Martin G., Mease, Ronnie C., Denmeade, Samuel R.

    Published in Bioorganic & medicinal chemistry (15-07-2009)
    “…Prostate-specific antigen (PSA) is a serine protease biomarker that may play a role in prostate cancer development and progression. The inhibition of PSA’s…”
    Get full text
    Journal Article
  19. 19

    N,N-Bis(2-mercaptoethyl)methylamine:  A New Coligand for Tc-99m Labeling of Hydrazinonicotinamide Peptides by Banerjee, Sangeeta R, Maresca, Kevin P, Stephenson, Karin A, Valliant, John F, Babich, John W, Graham, Wendy A, Barzana, Marlene, Dong, Qing, Fischman, Alan J, Zubieta, Jon

    Published in Bioconjugate chemistry (01-07-2005)
    “…Hydrazinonicotinamide (HYNIC) forms stable coordination complexes with Tc-99m when reacted with Tc(V)oxo species such as Tc-mannitol or other Tc-polyhydric…”
    Get full text
    Journal Article
  20. 20

    Abstract 5070: Prostate-specific membrane antigen (PSMA) targeted multiplexed siRNA-mediated gene silencing of CD46 and PD-L1 in prostate cancer by Chen, Zhihang, Krishnamachary, Balaji, Mironchik, Yelena, Banerjee, Sangeeta R., Pomper, Martin G., Bhujwalla, Zaver M.

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Abstract Small interfering RNA are suitable for gene silencing through a sequence-specific RNA interference process. The redundancy and complexity of molecular…”
    Get full text
    Journal Article